Personalis, Inc. Operating Cash Flow
Personalis, Inc. (PSNL) reported Operating Cash Flow of -$48.25 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-08-04
- Personalis, Inc. net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was -$25.77M.
- Personalis, Inc. net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was -$22.48M.
- Personalis, Inc. net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was -$22.25M.
- Personalis, Inc. net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was -$21.80M.
- Personalis, Inc. net cash provided by (used in) operating activities for fiscal 2025 was -$74.95M.
- Personalis, Inc. net cash provided by (used in) operating activities for fiscal 2024 was -$45.15M.
- Personalis, Inc. net cash provided by (used in) operating activities for fiscal 2023 was -$56.26M.
- Personalis, Inc. net cash provided by (used in) operating activities for fiscal 2022 was -$70.23M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$25.77M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | -$48.25M 10-Q · filed 2026-08-04 | -$70.49M derived: sum of 3 quarters · filed 2026-08-04 | -$92.30M derived: sum of 4 quarters · filed 2026-08-04 |
| 2026-03-31 | -$22.48M 10-Q · filed 2026-05-07 | -$44.72M derived: sum of 2 quarters · filed 2026-05-07 | -$66.53M derived: sum of 3 quarters · filed 2026-05-07 | -$79.46M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-12-31 | -$22.25M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$44.05M derived: sum of 2 quarters · filed 2026-02-26 | -$56.98M derived: sum of 3 quarters · filed 2026-08-04 | -$74.95M 10-K · filed 2026-02-26 |
| 2025-09-30 | -$21.80M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | -$34.74M derived: sum of 2 quarters · filed 2026-08-04 | -$52.70M 10-Q · filed 2025-11-04 | -$60.50M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-06-30 | -$12.94M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | -$30.90M 10-Q · filed 2026-08-04 | -$38.69M derived: sum of 3 quarters · filed 2026-08-04 | -$44.89M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-03-31 | -$17.96M 10-Q · filed 2026-05-07 | -$25.76M derived: sum of 2 quarters · filed 2026-05-07 | -$31.95M derived: sum of 3 quarters · filed 2026-05-07 | -$42.70M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | -$7.80M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$13.99M derived: sum of 2 quarters · filed 2026-02-26 | -$24.74M derived: sum of 3 quarters · filed 2026-02-26 | -$45.15M 10-K · filed 2026-02-26 |
| 2024-09-30 | -$6.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | -$16.94M derived: sum of 2 quarters · filed 2025-11-04 | -$37.35M 10-Q · filed 2025-11-04 | -$50.77M derived: sum of 4 quarters · filed 2025-11-04 |
| 2024-06-30 | -$10.74M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | -$31.16M 10-Q · filed 2025-08-05 | -$44.57M derived: sum of 3 quarters · filed 2025-08-05 | -$61.26M derived: sum of 4 quarters · filed 2025-08-05 |
| 2024-03-31 | -$20.41M 10-Q · filed 2025-05-06 | -$33.83M derived: sum of 2 quarters · filed 2025-05-06 | -$50.51M derived: sum of 3 quarters · filed 2025-05-06 | -$60.93M derived: sum of 4 quarters · filed 2025-05-06 |
| 2023-12-31 | -$13.42M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | -$30.10M derived: sum of 2 quarters · filed 2025-02-27 | -$40.51M derived: sum of 3 quarters · filed 2025-02-27 | -$56.26M 10-K · filed 2025-02-27 |
| 2023-09-30 | -$16.68M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | -$27.09M derived: sum of 2 quarters · filed 2024-11-06 | -$42.84M 10-Q · filed 2024-11-06 | -$59.60M derived: sum of 4 quarters · filed 2024-11-06 |
| 2023-06-30 | -$10.41M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | -$26.16M 10-Q · filed 2024-08-07 | -$42.92M derived: sum of 3 quarters · filed 2024-08-07 | -$57.69M derived: sum of 4 quarters · filed 2024-08-07 |
| 2023-03-31 | -$15.74M 10-Q · filed 2024-05-08 | -$32.51M derived: sum of 2 quarters · filed 2024-05-08 | -$47.27M derived: sum of 3 quarters · filed 2024-05-08 | -$74.62M derived: sum of 4 quarters · filed 2024-05-08 |
| 2022-12-31 | -$16.76M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | -$31.53M derived: sum of 2 quarters · filed 2024-02-28 | -$58.88M derived: sum of 3 quarters · filed 2024-02-28 | -$70.23M 10-K · filed 2024-02-28 |
| 2022-09-30 | -$14.77M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | -$42.11M derived: sum of 2 quarters · filed 2023-11-07 | -$53.47M 10-Q · filed 2023-11-07 | -$68.75M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-06-30 | -$27.35M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | -$38.71M 10-Q · filed 2023-08-08 | -$53.98M derived: sum of 3 quarters · filed 2024-02-28 | -$71.86M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-03-31 | -$11.36M 10-Q · filed 2023-05-03 | -$26.63M derived: sum of 2 quarters · filed 2024-02-28 | -$44.51M derived: sum of 3 quarters · filed 2024-02-28 | -$70.44M derived: sum of 4 quarters · filed 2024-02-28 |
| 2021-12-31 | -$15.27M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | -$33.15M derived: sum of 2 quarters · filed 2024-02-28 | -$59.09M derived: sum of 3 quarters · filed 2024-02-28 | -$70.83M 10-K · filed 2024-02-28 |
| 2021-09-30 | -$17.88M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-02 | -$43.81M derived: sum of 2 quarters · filed 2022-11-02 | -$55.55M 10-Q · filed 2022-11-02 | -$58.09M derived: sum of 4 quarters · filed 2023-02-23 |
| 2021-06-30 | -$25.93M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-03 | -$37.67M 10-Q · filed 2022-08-03 | -$40.21M derived: sum of 3 quarters · filed 2023-02-23 | -$56.33M derived: sum of 4 quarters · filed 2023-02-23 |
| 2021-03-31 | -$11.74M 10-Q · filed 2022-05-04 | -$14.28M derived: sum of 2 quarters · filed 2023-02-23 | -$30.40M derived: sum of 3 quarters · filed 2023-02-23 | -$45.75M derived: sum of 4 quarters · filed 2023-02-23 |
| 2020-12-31 | -$2.53M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | -$18.66M derived: sum of 2 quarters · filed 2023-02-23 | -$34.01M derived: sum of 3 quarters · filed 2023-02-23 | -$42.65M 10-K · filed 2023-02-23 |
| 2020-09-30 | -$16.12M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | -$31.48M derived: sum of 2 quarters · filed 2021-11-04 | -$40.12M 10-Q · filed 2021-11-04 | -$37.72M derived: sum of 4 quarters · filed 2022-02-24 |
| 2020-06-30 | -$15.35M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-04 | -$24.00M 10-Q · filed 2021-08-04 | -$21.59M derived: sum of 3 quarters · filed 2022-02-24 | -$31.23M derived: sum of 4 quarters · filed 2022-02-24 |
| 2020-03-31 | -$8.64M 10-Q · filed 2021-05-05 | -$6.24M derived: sum of 2 quarters · filed 2022-02-24 | -$15.88M derived: sum of 3 quarters · filed 2022-02-24 | -$26.78M derived: sum of 4 quarters · filed 2022-02-24 |
| 2019-12-31 | $2.40M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | -$7.23M derived: sum of 2 quarters · filed 2022-02-24 | -$18.14M derived: sum of 3 quarters · filed 2022-02-24 | -$18.07M 10-K · filed 2022-02-24 |
| 2019-09-30 | -$9.64M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | -$20.54M derived: sum of 2 quarters · filed 2020-11-05 | -$20.47M 10-Q · filed 2020-11-05 | -$17.27M derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-06-30 | -$10.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | -$10.84M 10-Q · filed 2020-08-06 | -$7.63M derived: sum of 3 quarters · filed 2021-02-25 | -$8.06M derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-03-31 | $66.00K 10-Q · filed 2020-05-07 | $3.27M derived: sum of 2 quarters · filed 2021-02-25 | $2.84M derived: sum of 3 quarters · filed 2021-02-25 | |
| 2018-12-31 | $3.20M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $2.77M derived: sum of 2 quarters · filed 2021-02-25 | $5.57M 10-K · filed 2021-02-25 | |
| 2018-09-30 | -$431.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-13 | $2.37M 10-Q · filed 2019-11-13 | ||
| 2018-06-30 | $2.80M 10-Q · filed 2019-08-13 | |||
| 2017-12-31 | $290.00K 10-K · filed 2020-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |